Biotech Values

[WorstLuck]

Dr. Jessica Ailani and Dr. Peter McAllister share their views on ELYXYB™ (celecoxib) oral solution, the first and only FDA-approved treatment of its kind for MIGRAINES.

How does changing an old drug (Celebrex/celecoxib) from pill to liquid actually address the migraine market when there are so many OTC and Rx NSAID alternatives that are cheaper and/or safer?

Looks like a marketing gimmick. Doesn't mean it can't be profitable since many marketing gimmicks are. But it doesn't address any unmet need or actually improve outcomes in a meaningful way compared to available treatments.